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CHAPTER-I 
 
INTRODUCTION 
          The Indian subcontinent is enriched by a variety of flora- both aromatic and medicinal 
plants. This is due to the wide diversity of climatic conditions in India ranging from deserts to 
swam plants. In India, 75% of the populations depend on the traditional system of medicines 
for relief. In the early stages, the science of medicine developed around those plants which 
had curative properties. A continued search for medicinal plants during the last several 
centuries has given rise to a long list of plants which are of great use in the treatment of 
diseases and for promoting health. 
          The WHO is now actively encouraging developing countries to use herbal medicine 
with they have been traditionally used for centuries. Natural  products as a basis for new 
drugs have great promise and it is gratifying to note that the WHO have shown an abiding 
interest in plant derived medicines, described in the folklore of various countries.[1] 
         Traditional remedies invariably involve crude plant extracts containing multiple 
chemical constituents, which vary in potency from highly active to very weak. [2] 
WORLD SITUATION ON TRADITIONAL MEDICINE [3] 
          Traditional medicine is a very important part of health care. Most population in the 
developing countries still relies mainly on indigenous traditional medicine for satisfying their 
primary health care needs. Traditional medicine has not however been incorporated in most 
national health systems and the potential of services provided by traditional practitioners is 
far from being fully utilized. Herbal medicines are of great importance to the health 
individuals and communities but their quality assurance needs to be developed. During the 
last decade, in many developed countries there has also been a growing interest in herbal 
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medicine, acupuncture and alternative system of medicines and other types of traditional 
medicines has occurred. Proper use of these different types of medicine has therefore become 
a concern.  
HERBAL DRUGS IN TRADITIONAL MEDICINES 
          Herbal drugs constitute a major part in all the traditional system of medicine. Herbal 
medicine is a triumph of popular therapeutic diversity. Plants above all other agents have 
been used for medicine from time immemorial because they have fitted the immediate 
personal need, are easily accessible and inexpensive. 
DRUG DISCOVERY FROM NATURAL PRODUCTS 
          According to surveys and other research carried out in different countries, scientific 
medicine in developing countries serves only a minority, while the rest of the population 
attends to its health needs through the process called traditional medicine, aboriginal 
medicine, or folk medicine, processes based essentially on the use of low-cost medicinal 
plants that are easily accessible to the entire population. 
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 Various strategies for the discovery of drugs from natural resources: 
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          About 30% of the drugs sold worldwide are based on natural products. Though 
recombinant proteins and peptides account for an increasing market volume, the superiority 
of low- molecular- mass compounds in human disease therapy remains undisputed, mainly 
due to more favorable compliance and bioavailability properties. In the past, new therapeutic 
approaches have often evolved from research involving natural products. Numerous 
examples from medicine impressively demonstrate the innovative potential of natural 
compounds and their impact on progress in drug discovery and development. [4] 
 
EPILEPSY 
          Epilepsy is a common neurological abnormality, affecting about 1% of world 
population. A seizure means paroxysmal abnormal discharge at high frequency from 
aggregate of neurons in cerebral cortex. Epilepsy is a condition characterized by recurrent 
episodes of such seizures. Inspite of several advancements in the field of synthetic drug 
chemistry, plants continue to be one of the major raw materials for drugs treating various 
ailments of humans. Plant remedies are effective and without side effects provided recovery, 
if they are selected properly [5-6]. 
         The current therapy of epilepsy with modern antiepileptic drugs is associated with side 
effects, dose-related and chronic toxicity, as well as teratogenic effects and approximately 
30% of the patients continue to have seizures with current antiepileptic drugs therapy [7-9].  
Medicinal plants are believed to be an important source of new chemical substances with 
potential therapeutic effects [10]. Several plants used for the treatment of epilepsy in different 
systems of traditional medicine have shown activity when tested in modern bioassays for the 
detection of anticonvulsant activity [11] and many such plants are yet to be scientifically 
investigated. 
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Eg: 
 Ricinous communis L 
 Datura stamoniumL 
 Bacopa monnieri(L) 
 Allium sativum L 
 Asparagus racemosus willd. 
          For the purposes of drug treatment, it is more useful to classify patients according to 
the type of seizure they experience. 
Nature and mechanism of seizures 
          Almost a century ago, John Hughlings Jackson, the Father of modern concepts of 
epilepsy, proposed that seizures were caused by “occasional, sudden, excessive, rapid and 
local discharges of gray matter”, and that a generalized convulsion resulted when normal 
brain tissue was invaded by the seizure activity initiated in the abnormal focus. The 
electroencephalogram (EEG) amply demonstrates that seizures are associated with abnormal 
and sometimes massive electrical discharge in the brain and serves as the basic method of 
differential diagnosis of the epilepsies.[12] 
Classification of epilepsies 
I. Generalized seizures 
a) Generalized tonic-clonic seizures 
b) Absence seizures 
c) Atonic seizures 
d) Myoclonic seizures 
e) Infantile spasms (Hypsarrhythmia) 
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II. Partial seizures 
a) Simple partial seizures 
b) Complex partial seizures 
c) Simple partial or complex partial seizures secondarily generalized.[13] 
Medication for epilepsy 
          Epilepsy cannot be cured with medication. However, with the right type and strength of 
medication, the majority of people with epilepsy do not have seizures. The medicines work 
by stabilizing the electrical activity of the brain. We need to take medication every day to 
prevent seizures. 
          Medicines used to treat epilepsy include: carbamazepine, sodium valproate, 
lamotrigine, phenytoin, oxcarbazepine, ethosuximide, gabapentin, levetiracetam, tiagabine, 
topiramate, vigabatrin, phenobarbital, primidone and clonazepam. They come in different 
brand names. 
Other medication 
 Surgery to remove a small part of the brain which is the underlying cause of the 
epilepsy. Surgery is only possible for a minority of people with epilepsy and it may be 
considered when medication fails to prevent seizures, especially partial seizures. Only a 
small number of people with epilepsy are suitable for surgery and, even for those, there 
are no guarantees of success. Also, there are risks from operations. However, surgical 
techniques continue to improve and surgery may become an option for more and more 
people in the future. 
 Vagal nerve stimulation is a treatment for epilepsy where a small generator is 
implanted under the skin below the left collar bone. The vagus nerve is stimulated to 
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reduce the frequency and intensity of seizures. This can be suitable for some people with 
seizures that are difficult to control with medication. 
 The ketogenic diet is a diet very high in fat, low in protein, and almost carbohydrate-
free. This can be effective in the treatment of difficult-to-control seizures in some 
children. 
 Complementary therapies such as aromatherapy may help with relaxation and relieve 
stress, but have no proven effect on preventing seizures. 
 Counseling. Some people with epilepsy become anxious or depressed about their 
condition. A doctor may be able to arrange counseling with the aim of overcoming such 
feelings. Genetic counseling may be appropriate if the type of epilepsy is though to have 
an hereditary pattern.[14] 
Mechanism of action of anti-epileptic drugs 
a) Enhancement of GABA action 
b) Inhibition of sodium channel function 
c) Inhibition of calcium channel function[15] 
 
RHEUMATOID ARTHRITIS [16] 
   Rheumatoid arthritis is an immunologic disease that not only affects mobility but the 
quality of life as well. NSAIDs provide only symptomatic relief in inflammation and pain but 
have little effect on the progression of bone and cartilage destruction where cytokines IL-1 
and TNFα play a major role in pathogenesis. 
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PATHOGENESIS OF RHEUMATOID JOINT DAMAGE AND SITES OF ACTION 
OF ANTIRHEUMATOID DRUGS 
Immunosuppressants                                    Glucocorticoids 
 
 
 
 
 
 
 
 
   
 Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic 
inflammation of the joints. While inflammation of the tissue around the joints and 
inflammatory arthritis are characteristic features of rheumatoid arthritis, the disease can also 
cause inflammation and injury in other organs of the body. Autoimmune diseases are 
illnesses that occur when the body's tissues are mistakenly attacked by their own immune 
system. The immune system contains a complex organization of cells and antibodies 
designed normally to "seek and destroy" invaders of the body, particularly infections. Patients 
with autoimmune diseases have antibodies in their blood that target their own body tissues, 
where they can be associated with inflammation. Because it can affect multiple other organs 
of the body, rheumatoid arthritis is referred to as a systemic illness and is sometimes called 
rheumatoid disease. 
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Rheumatoid arthritis is a common rheumatic disease, affecting approximately 1.3 
million people in the United States, according to current census data. The disease is three 
times more common in women as in men. It afflicts people of all races equally. The disease 
can begin at any age and even affects children (juvenile rheumatoid arthritis), but it most 
often starts after 40 years of age and before 60 years of age. In some families, multiple 
members can be affected, suggesting a genetic basis for the disorder [17] 
Symptoms and diagnosis of rheumatoid arthritis 
         Symptoms include joint swelling, pain, morning joint stiffness, poor sleep, fatigue, loss 
of weight and feeling of having flu symptoms. Rheumatoid arthritis is diagnosed by 
rheumatoid factor these are abnormal antibodies (IgG) which are present in blood. These are 
reacted with antigen and form antigen-antibody complex that leads to pain and inflammation 
of synovial membrane. The American College of Rheumatology requires at least four of the 
following seven criteria to confirm the diagnosis [18-19] 
• Morning stiffness around the joint that lasts at least 1 hour  
• Arthritis of three or more joints for at least 6 weeks  
• Arthritis of hand joints for at least 6 weeks  
• Arthritis on both sides of the body for at least 6 weeks  
• Rheumatoid nodules under the skin  
• Rheumatoid factor present in blood testing  
• Evidence of rheumatoid arthritis on X-rays  
 
                                                                                                         Introduction 
 
Department of Pharmacognosy, MMC Page 11 
 
Principles of management of rheumatic arthritis [20] 
 Rest to acutely inflamed joints 
 Reduction of pain and inflammation by use of anti inflammatory drugs. 
 Prevention of articular damage by early use of drugs modifying the disease course 
(DMARD) with rapid escalation. 
 Use of combination therapy. 
 Use of glucocorticoids as ancillary measures. 
 Graded exercises and physiotherapy. 
 Treatment of comorbid conditions such as infection and osteoporosis. 
 Use of biological agents if DMARD fails. 
 Modification of the diet using more omega-3 fatty acids in place of omega-9 fatty 
acids in their respect, vegetarian diet may be beneficial. 
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CHAPTER - II 
  REVIEW OF LITERATURE 
The literature review of Gmelina arborea (Roxb.) reveals that the following works 
have been already done on the plant. 
PHARMACOLOGICAL ACTIVITY 
1. Shirwaikaret.A et al., (2003) have reported the alcoholic extract of leaves of Gmelina 
arborea at the dose level of 200mg/kg increased the wound contraction rate, skin breaking 
strength, hydroxyl proline content and dry granuloma weight and decreased epithelization 
period in the testominals.[21] 
2. Panja.A.K. et al., (2003) have reported the role of Dasamool in controlling 
hypothyroidism .Dasamool consist of 11 plants like Gmelina arborea, Oroxylumindicum etc. 
[22] 
3. Sangeetasinha et al., (2006) have reported the effect of aqueous extract of Gmelina 
arborea bark and fruit on paraquat and H2O2 induced oxidative stress using liver slice 
culture. Both paraquat & H2O2 were found to be cytotoxic as measured by release of lactate 
dehydrogenase from liver slice culture. Addition of bark & fruit extracts along with these 
cytotoxic agents led to decrease in lactate dehydrogenase release. [23] 
4. Patil.S.M. et al., (2009) have studied the antioxidant activity of methanolic extracts of 
stem bark of Gmelina arborea Roxb using various in-vitro assays. The antioxidant activity of 
MEGA was evaluated by using DPPH method, reducing power assay, nitric oxide scavenging 
activity &H2O2 scavenging activity. Total phenolic content was also determined by using 
gallic acid as a standard. [24] 
5. Kulkarn.Y et al., (2010) have reported the aqueous extract of Gmelina arborea was found 
safe in acute toxicity studies when tested in rodents. [25] 
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6. Nayak et al., (2012) have reported the antibacterial, antioxidant &anti diabetic activities of 
different extracts of fruits of plant Gmelina arborea using ethanol, ethyl acetate, n-butanol 
&petroleum ether as solvents. The ethanol extract showed good antioxidant activity when 
compared to other three extracts. All the extracts were able to reduce sugar level in blood. 
Ethanol extract was found to have good antidiabetic activity in comparison to other extracts. 
[26] 
7. Bhabani Shankar Nayak et al., (2012) have reported the diuretic effect of different fruit 
extracts of the plant Gmelina arborea using ethanol, ethyl acetate, n-butanol &petroleum 
ether as solvents. The n-butanol extract showed better diuretic effect in comparison to other 
extracts. [27] 
PHYTOCHEMICAL STUDIES 
8. Hosny .M et al., (1998) have isolated 12 new acylated iridoid glycosides named 
gmelinosides A-L (2-13) from the leaves of Gmelina arborea. [28] 
9. Sharma. A et al., (1998) have reported that the Gmelina arborea was highly salt sensitive 
and withstood salinity upto 2.5 ds/m. [29] 
10. Thirunavoukkarasu.M et al., (1998) have studied the micropropagation of Gmelina 
arborea through axillary bud culture and reported that the epicromic &crown regions of a 6 
year old Gmelina arborea tree were used to initiate shoot cultures. Explants from the 
epicromic region produced 2.7+0.1 shoot less/explants when cultured on MC cown’s medium 
for woody plants supplemented with 2% sucrose. About 80% of the in-vitro regenerated 
shoots rooted on IBA (1.5mg/l) supplemented MC cown’s medium within 7-9 days of 
culture. [30] 
11. VinayaS.Ghate et al., (1998) have evaluated Bruhatpanchmula germplasm. Stem 
cuttings of Gmelina arborea shows 6% rooting response using quick dip method in IBA 
(4000ppm).vegetative propagation was successful in Gmelina arborea. [31] 
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12. Behera .P.R et al., (2008) have regenerated Gmelina arborea using cotyledonary node 
explants. Multiple shoots were induced on Murashige &Skoog’s medium supplemented with 
6-BA, TDZ. [32] 
13. Moronkola D.O et al., (2009) have reported the chemical composition of the fruit oil of 
Gmelina arborea by capillary gas chromatography, gas chromatography and mass 
spectrometry. [33] 
14. ShafaqS.S. et al., (2011) have analysed the aqueous & hydro alcoholic extracts of stem 
bark of Gmelina arborea by HPTLC using umbelliferone. The percentage of umbelliferone in 
both extracts was 0.091%w/w & 0.069%w/w.[34] 
ETHNOMEDICAL INFORMATION 
15. U.P.Bhattachary et al., (1998) have reported the uses of Gmelina arborea for treating 
leach-bite, snake bite, scorpion-sting, rat bite and insect bite. [35] 
16. Devi Y.N et al., (2008) have studied the ethnobotany survey for the family verbenaceae. 
Gmelina arborea has immense food and medicinal value.[36] 
 
OTHER SPECIES 
Gmelina asiatica 
PHARMACOLOGICAL ACTIVITY 
1. Nallellasriramulu et al., (1998) have reported the Gmelina asiatica was used in veterinary 
practices.[37] 
2.Madhu K.B et al.,(2001) have studied the hexane & methanolic extract of Gmelina 
asiatica leaves for antimicrobial activity against 6 gram-positive bacteria,4 gram- negative 
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bacteria ,3 fungi & 3 yeast by  the cup plate agar diffusion method. Methanolic extract 
showed very good antimicrobial activity against all the selected strains .Hexane extracts were 
devoid of activity. [38] 
3. Kottaimuthu .R. et al., (2009) have reported that the Gmelina asiatica stem was used for 
leucorrhoea. [39] 
4. MadhuKatyayani et al., (2010) have reported the presence of lignans in Gmelina asiatica 
roots. The study evaluated the effect of ethyl acetate extract of roots (EGAR) on estrogen 
receptor positive (MCF-T) and negative (MDA-MB-231) human breast cancer cell lines. The 
IC50 of EGAR on the cells was determined using MTT assay kit. [40] 
PHYTOCHEMICAL STUDIES 
5. Satyanarayana T. et al., (2007) have studied the phytochemical nature of Gmelina 
asiatica root. The bioguided extraction and fractionation of the alcoholic extract of the roots 
of Gmelina asiatica afforded a new flavone derivatives named oratifolin which has been 
isolated & identified together with the known compounds (+)sesamin, sakuranetin, (-) 
piperitol,(+) pinoresinol.[41] 
ETHNOMEDICAL INFORMATION 
6. VenkataRaju RR et al., (1998) have reported the ethnomedical information like 
vernacular names, medicinal property, part used &mode of administration for Gmelina 
asiatica. [42] 
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CHAPTER-III 
AIM AND SCOPE OF THE STUDY 
Gmelina arborea is an unarmed, moderately sized to large deciduous tree, about 30 m 
or more in height and a diameter of upto 4.5 m. [43] Bark and the root are of medicinal value 
and used by Santhal and Gondbheels. The fruit juice is demulcent and used in curing 
gonorrhoea and cough and also to remove foetid discharges and worms from the ulcer. [44] 
The present study has been planned to carry out the pharmacognostic, phytochemical 
and pharmacological evaluation of the ethanolic extract of the leaves of Gmelina arborea. 
1.  Pharmacognostical studies  
 Macroscopical studies. 
  Microscopical studies 
 Quantitative analytical parameters 
 Physico chemical parameters 
 Powder analysis 
2. Phytochemical studies 
 Organoleptic evaluation 
 Preliminary phytochemical screening 
 Quantitative estimation of phytoconstituents 
 Chromatography (TLC & HPTLC) 
3. Pharmacological studies 
A. In vitro antioxidant activity 
 DPPH Assay 
 Reducing power assay 
 Phosphomolybdenum method 
B. In-vitro anti-arthritic activity 
C. In-vivo anti -epileptic activity 
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CHAPTER-IV 
PLANT PROFILE 
 
Gmelina arborea is a beautiful fast growing deciduous tree occurring naturally 
throughout greater part of India. The genus was named after J.C.Gmelin, an 18thcentury 
German botanist. The species name means treelike, from the Latin ‘arbor’ (tree) [45] 
BIOLOGICAL SOURCE   : Gmelina arborea Roxb. 
FAMILY  : Verbanaceae. 
SYSTEMATIC POSITION 
 Kingdom     : Planta 
 Subkingdom                                       : Angiosperm 
 Super division                                     : Eudicots 
 Division                                              : Asterids 
 Class                                                   : Equisetopsida 
 Order                                                  : Laiales 
 Family                                                : Lamiaceae 
 Genus                                                 : Gmelina 
 Species                                                : G.arborea 
 SYNONYM 
Gmelina rheedii Hook.   
 COMMON NAME 
Umi – thekku 
VERNACULAR NAME 
English                                                      : Candhar tree, White teak. 
Sanskrit                                                     : Kasmari 
Hindi                                                          : Gambhar, Khambhari 
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Kannada                                                     : Shivanigida, Shivani 
Malayalam                                                 : Kumizhu, Kumpil 
Telugu                                                        : Pegummudu, Pegusmmadi, ummithekku 
Tamil                                                          : Kumishan, Kumizhan 
GEOGRAPHICAL DISTRIBUTION 
Throughout India, Ceylon-Malayan and Philippine Islands. In India, Gmelina 
arborea occurs extensively from the Ravi eastwards in the sub-Himalayan tracts, common 
throughout Assam and adjoining areas of Northern West Bengal ,also in southern Bihar and 
Orissa. 
HABIT AND HABITAT OF THE PLANT 
It is a moderate sized unarmed deciduous tree, reaching 30m high and occurs in a 
variety of forest habitats. Bark grayish yellow, rather corky; branchlets and young parts 
clothed with fine white mealy pubescence. Gmelina arborea is a fast growing tree, which 
grows on different localities and prefers moist fertile valleys with 750–4500 mm rainfall. It 
does not thrive on ill-drained soils and remains stunted on dry, sandy or poor soils; drought 
also reduces it to a shrubby form. 
ETHNOMEDICAL INFORMATION  
1. The leaf paste is used for cephalgia and the leaf juice is a good wash for foul ulcers. 
2. The flowers are used in treating leprosy and skin diseases. 
3. The fruits are used for promoting the growth of hair and for anaemia, leprosy, ulcers, 
constipation, strangury, leucorrhoea and colitis. 
4. The root is used for hallucination, fever, dyspepsia, hyperdipsia, haemorrhoids.Bark is 
useful in fever and dyspepsia.[45-48] 
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Fig.2: HERBARIUM OF Gmelina arborea Roxb. 
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CHAPTER-V 
PHARMACOGNOSTICAL STUDIES 
Collection of specimen 
 The leaves of Gmelina arborea Roxb. was collected in and around Madurai 
Medical College Campus during the month of August. The leaves were authenticated by a 
taxonomist at American College, Madurai. A voucher specimen of the leaves of Gmelina 
arborea Roxb. was placed at the Dept.of Pharmacognosy, College of Pharmacy, Madurai 
Medical College. A copy of the same was presented in Fig.2. The fresh leaves were used for 
the macroscopic, microscopic evaluation and for the determination of leaf constants. The 
leaves were collected, washed and shade dried. The shade dried leaves were powdered, 
sieved and used for physico chemical analysis and for powder microscopy. 
 
SECTION-A 
MACROSCOPICAL STUDIES 
Gmelina arborea is a large deciduous tree with a straight trunk. It is wide spreading 
with numerous branches forming a large shady crown [49, 50] 
Bark 
The tree has smooth, pale ashy- grey or grey to yellow bark with black patches and 
conspicuous corky circular lenticels. 
Leaves (Fig.4.1, 4.2) 
Leaves are simple, opposite- decussate, broadly ovate, 10-25cm long and 7-20cm 
wide, apically long acuminate apex or caudate, entire on mature plants but strongly toothed or 
lobed on young plants, cordate or trunkate base, densely tomentose above when young, 
becoming glabrous above when mature, permanently densely fulvulous-tomentellous with 
Fig.3: HABIT & HABITAT OF Gmelina arborea 
 
 
 
 
 
Fig.4.1: DORSAL VIEW OF THE LEAF OF Gmelina arborea 
 
 
                         
 
 
 
                                                   
                 Fig.4.2: VENTRAL VIEW OF THE LEAF OF Gmelina arborea 
 
                                  
  Fig.5: FLOWERS OF Gmelina arborea 
 
                                
 
 
Fig.6: FRUIT OF Gmelina arborea 
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stellate hairs beneath and shortly cuneate; petioles cylindrical 5-15cm long, puberulous or 
glabrous and glandular at the top. 
Flowers (Fig.5) 
Flowers appears with or sometimes before the young leaves, usually in small cymes 
of about 3 flowers on the densely fulvous-hairy panicle branches reaching 8 to 40cm long. 
Flowers are  abundant, scented, reddish, brown or yellow and about 2.5 to 5cm in diameter; 
bracts 8mmlong,linear-lanceolate; calyx  broadly campanulate,densely fulvous-hairy 
externally, the rim with 5small,triangular, acute teeth; Corolla large, showy varying from 
brilliant orange to reddish or brownish yellow, tubular below, obliquely funnel form at the 
throat, densely hairy outside, reaching 3.8cm long, the limb 2-lipped,the upper lip often 
orange, deeply divided into 2 oblong ,obtuse, backwardly curled lobules, the lower lip often 
lemon yellow, upto twice as long as the upper and 3-lobed. 
Fruits (Fig.6) 
Drupe, 2-2.5cm long, obovoid or pyriform, seated on the enlarged calyx, glossy and 
yellow when ripe; exocarp succulent and aromatic; endocarp bony and usually  
2- celled. Seeds 1-3, lenticular and exalbuminous. 
Root bark 
The mature root-bark when fresh is yellow in colour. Dry pieces are curved and 
channeled, thinner ones forming single quills. The external surface is ryesed due to the 
presence of vertical cracks, ridges, fissures and numerous lenticels. 
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SECTION –B 
                                           MICROSCOPICAL STUDIES 
Materials and methods [51-62] 
 The leaves of the plant were subjected to microscopical evaluation. The samples of 
leaves were cut and removed from the plant and fixed in FAA (Formalin, 5ml; Acetic acid, 
5ml; Ethyl alcohol, 90ml). After 24h of fixing, the specimens were dehydrated with graded 
series of t-butyl alcohol. Infiltration of the specimens was carried by gradual addition of 
paraffin wax (M.pt-58-60oC) until TBA solution attained super saturation. The specimens 
were cast into paraffin blocks.  
Sectioning 
 The paraffin embedded specimens were sectioned with help of rotary microtome. The 
thickness of the sections was 10-12µm. De-waxing of the sections was carried out by 
customary procedure. The sections were stained with toluidine blue, since it is a 
polychromatic stain. The staining results were remarkably good; and some cytochemical 
reactions were also occurred. The dye rendered pink color to the cellulose walls, blue to the 
lignified cells, violet to the mucilage and blue to the protein bodies and also stained with 
safranin.  
Leaf clearing 
Paraffin embedded leaf was used for para-dermal sections. From these sections, the 
epidermal layers as well as vein islets were studied. Another method employed was clearing 
leaf fragments by immersing the material in alcohol (to remove chlorophyll) followed by 
treating with 5% sodium hydroxide. The material was rendered transparent due to loss of cell 
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contents. Epidermal peeling by partial maceration employing Jeffrey’s maceration was also 
done. Glycerin mounted temporary preparations were made for cleared materials.   
Powdered materials of different parts were cleared with sodium hydroxide and 
mounted in glycerin medium after staining. Different cell component were studied. 
Photomicrographs 
The photographs of different magnifications were taken with Nikon lab photo 2 
microscopic units. For normal observations bright field was used and for the study of starch 
grains and lignified cells, polarized light was employed. Since these structures have 
birefringent property, under polarized they appear bright against dark background. The 
magnifications of the anatomical features are indicated by the scale-bars in the photographs.  
Microscopical observation 
Leaf 
The leaf consists of a thick midrib and a thin lamina with densely tomentose abaxial 
surface (Fig.7.1).The midrib is flat on the adaxial side and thick and wide on the abaxial side. 
(Fig.7.2) The lateral vein is also prominent with thick, hanging abaxial part (Fig.7.3). 
The midrib is 550µm thick and 520µm wide. The epidermal layer consists of small, 
papillate thick walled cells. The ground tissue is homogenous and includes thin walled, 
compact parenchyma cells. The vascular strand consists of two arc shaped collateral bundles. 
There are short parallel lines of small thick walled xylem elements and thick arc of phloem 
situated on the lower part of the xylem strand. (Fig.8.1) 
The lateral vein also has small, slightly papillate thick walled epidermal cells, 
homogenous compact parenchyma cells and single bowl shaped collateral vascular bundle 
(Fig.7.3) 
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Lamina (Fig.8.1) 
The lamina is 120µm thick. It consist of thick and wide, vertically oblong epidermal 
cells with prominent cuticle. The abaxial epidermis is thin and the cells are cylindrical. The 
epidermis bears dense non glandular and glandular trichomes. The mesophyll cells consist of 
adaxial palisade and abaxial spongy parenchyma cells. The palisade cells are single layered 
with thin vertical, long cylindrical cells and cylindrical, spherical or lobed parenchyma cells 
in spongy mesophyll tissue. 
Venation pattern (Fig.9.1, 2) 
The venation is densely reticulate. The primary, secondary and tertiary veins are thin, 
but distinct (Fig.9.1). The vein- islets are wide and well defined with prominent vein –
boundaries. The vein- terminations, when present are long, slender and forked at the tip 
(fig.9.2).There are also long, unforked terminations. 
Stomata (fig10.2, 3) 
 The stomata occur on the abaxial surface of the lamina. The stomata are circular 
measuring 50µm in diameter. Cell walls of the guard cells are thick walled. The stomata are 
diffuse in distribution. The epidermal cells small, angular and thick walled and straight. The 
stomata are anomocytic others are actinocytic having four or five radiating subsidiary cells. 
Stomata are clear and well defined.  
Non glandular trichomes (fig.10.1) 
Long, multicellular unbranched epidermal trichomes are abundant on the abaxial 
epidermis; the trichomes are two or three celled; narrow and pointed at the tip. The trichomes 
are mostly curved. The trichomes are 300-3500µm long. 
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SECTION-C 
QUANTITATIVE ANALYTICAL MICROSCOPY [63, 64] 
 Quantitative analytical microscopy is useful for measuring the cell contents of the 
crude drugs, which help in their identification, characterization, and standardization. A clear 
idea about the identity and characteristic features of the drug can be obtained after several 
determinations; the characteristic’s number obtained was noted and compared with a standard 
value to find out whether it is within the range. 
 
Determination of stomatal number and stomatal index 
Stomatal number: The average number of stomata/sq.mm area of each surface of a leaf 
epidermis is termed as stomatal number    
Stomatal index: The stomatal index is the percentage which the number of stomata formed 
to the total number of epidermal cells, each stoma being counted as one cell. 
To study the stomatal morphology (type of stomata), stomatal number and stomatal index of 
leaf, the leaf was subjected to epidermal peeling.  
Procedure  
The leaf was cleared by boiling with chloral hydrate solution or alternatively with 
chlorinated soda. The upper and lower epidermis was peeled out separately by means of 
forceps. The cleared leaf was placed on a slide and mounted in glycerin. A camera lucida and 
drawing board was placed and a stage micrometer was inserted for making the drawing scale. 
A square of 1mm was drawn by means of stage micrometer. The slide with cleared leaf 
(epidermis) was placed on the stage of the microscope and examined under 45X objective 
and 10X eye piece. The epidermal cell and stomata was traced. The numbers of stomata 
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present in the area of 1sq. mm. including the cell if at least half of its area lies within the 
square was counted. The result for each field was calculated and the average number of 
stomata per sq. mm was determined and their values were tabulated in Table 1. 
For stomatal index, the glycerin mounted leaf peeling as mentioned above was made and 
circle (O) like mark for each stomata and a cross (X) like mark for each epidermal cells was 
marked on the chart paper. The stomatal index was calculated by using the formula,  
                  Stomatal index = S/ (E + S) x 100  
Where S was the number of stomata in 1sq mm area of leaf and E was the number of 
epidermal cells (including trichomes) in the same area of leaf. The values were tabulated in 
Table 1. 
Determination of Vein Islets and Vein Terminations 
The term vein islet is used to denote the minute area of photosynthetic tissue encircled 
by the ultimate divisions of conducting strands. The number of vein islet/sq.mm of leaf 
fragments is known as vein islet number. An ultimate free end or termination of a veinlet is 
termed as veinlet termination. The number of vein terminals present in one sq.mm area of 
leaf fragment is termed as veinlet termination number  
Procedure  
The fragment of leaf lamina with an area of not less than 1sq mm excluding the 
midrib and the margin of the leaf was taken. The fragments of leaf lamina were cleared by 
heating in a test tube containing chloral hydrate solution on a boiling water bath until clear. 
The cleared fragments were stained with saffranin solution and a temporary mount was 
prepared with glycerol solution. The stage micrometer placed on the microscopic stage, 
examined under 10X objective and 6X eye piece and an area of 1 sq mm square was drawn. 
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The cleared leaf piece was placed on the microscope stage, the vein islets and vein terminals 
included in the square was drawn. The number of vein islets and terminals within the square 
were counted. The results obtained for the number of vein islets and terminals in1sq mm were 
tabulated in Table 1. 
 
Table 1: Quantitative analytical microscopical 
Parameters of the leaf of Gmelina arborea 
 
S. No. 
 
Parameters* Values 
obtained* 
1. Stomatal number in 
lower epidermis 
41.33±0.66 
2. Stomatal index in lower 
epidermis  
27.33±0.33 
3. Vein islet number 35.67±0.88 
4. Vein termination number 19±0.58 
* mean of 3 readings ± SEM 
 
                                                          SECTION-D 
 PHYSICOCHEMICAL PARAMETERS 
Determination of Moisture Content (Loss on Drying) [65, 66]  
An accurately weighed 10g of powdered drug was placed in a tarred weighing bottle. 
Then the bottle was dried at 105oC for 5h and weighed. The drying and weighing was 
continued at one hour intervals until the difference between the two successive weighing is 
not more than 0.25%. The loss on drying was calculated with reference to the amount of 
powder taken. The readings were tabulated in Table 2. 
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TABLE-2 
PERCENTAGE OF LOSS ON DRYING 
 
 
 
 
 
 
 
Determination of Ash values [65, 66]   
Ash Content [67]    
The residue remaining after incineration is the ash content of crude drug, which 
simply represents inorganic salts naturally occurring in the drug or adhering to it or 
deliberately added to it as a form of adulteration. The total ash, acid insoluble ash and water 
soluble ash are generally determined. 
Procedure 
Determination of Total Ash 
 An accurately weighed 2g of air dried powdered drug was taken in a tarred silica 
crucible and incinerated at a temperature not exceeding 450oC, upto 6hrs until free from 
carbon, then allowed to cool and weighed. The percentage of ash was calculated with 
reference to the air dried drug.   
OBSERVATION 
NUMBER 
LOSS ON DRYING 
(%)w/w 
1                 8.5 
2                 9.6 
3                 9.1 
4                 9.1 
5                 8.9 
  
Minimum                 8.5 
Average                 9.0 
Maximum                 9.6 
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Determination of Acid Insoluble Ash 
The total ash obtained from the previous procedure was mixed with 25ml of 2M 
hydrochloric acid and boiled for 5min in a water bath, and then the insoluble matter was 
collected in an ashless filter paper (Whatmann) and washed with hot water, dried and ignited 
for 15min at a temperature not exceeding 450oC, cooled in a desiccator and weighed. The 
percentage of acid insoluble ash was calculated with reference to the air dried drug.     
Determination of Water Soluble Ash 
The total ash obtained from the previous procedure was mixed with 25ml of water and 
boiled for 5min in a water bath, and then the insoluble matter was collected in an ashless 
filter paper and washed with hot water, dried and ignited for 15min at a temperature not 
exceeding 450oC, cooled in a desiccator and weighed. The insoluble matter was subtracted 
from the weight of the total ash; the difference in weight represents the water soluble ash. 
The percentage of water soluble ash was calculated with reference to the air dried drug. The 
values in respect of the total ash values, acid insoluble ash, water soluble ash and water 
insoluble ash were tabulated in Table 3. 
Determination of sulphated Ash [68] 
An accurately weighed 2g of air dried powdered drug in a tarred silica crucible which 
was previously ignited and cooled before weighing at a temperature not exceeding 450°C. 
The residue was moistened with 1ml of concentrated sulphuric acid, ignited at 800 ± 25°C 
until all black particles have disappeared. It was then cooled; again sulphuric acid was added 
and ignited. It was cooled and the percentage of sulphated ash was calculated with reference 
to air dried drug. The results obtained were presented in Table.3. 
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Table-3 
ASH VALUE 
 
 
 
 
 
 
Determination of Extractive Values [66, 69] 
The extractive values are the important factor to determine the amount of active 
principle or phytocostituents present in the plant materials, when extracted with suitable 
solvents. The extraction of crude plant materials with various solvents gives a solution 
containing different phytoconstituents. Composition of the phytoconstituents in a particular 
solvent depends upon the nature of drugs and the solvents used. This is an important tool for 
the analysis of crude plant materials for its identity, purity and quality. 
Procedure 
Determination of ethanol soluble extractive 
             An accurately weighed 5g of the air dried coarsely powdered drug was macerated 
with 100ml of ethanol in a closed flask for 24h, shaking frequently during the first 6h and 
allowed to stand for 18h. Thereafter filtered rapidly, taking precautions against loss of 
ethanol. Then evaporate 25ml of the filtrate to dryness in a tarred china dish at 105oC and 
weighed. The percentage of ethanol soluble extractive was calculated with reference to the air 
dried drug. 
OBSERVATION 
NUMBER 
TOTAL  
ASH % 
ACID 
INSOLUBLE 
ASH% 
WATER 
SOLUBLE 
ASH% 
SULPHATED 
       ASH 
        % 
              1 5 0.33  9.22 
              2 8 0.21  9.22 
              3 9.5 0.16  9.03 
              4 8  3.9  
              5 8  3.5  
              6 8.5  3.4  
Minimum 5 0.16 3.4 9.03 
Average 7.8 0.23 3.6 9.16 
Maximum 9.5 0.33 3.9 9.22 
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Determination of water soluble extractive:      
An accurately weighed 5g of the air dried coarsely powdered drug was macerated 
with 100ml of chloroform water in a closed flask for 24h, shaking frequently during the first 
6h and allowed to stand for 18h. Thereafter filtered rapidly, taking precautions against loss of 
chloroform water. Then evaporate 25ml of the filtrate to dryness in a tarred china dish at 
105oC and weighed. The percentage of water soluble extractive was calculated with reference 
to the air dried drug. 
Determination of petroleum ether soluble extractive:     
The procedure adopted under ethanol soluble extractive was followed using petroleum 
ether as a solvent. 
Determination of chloroform soluble extractive: 
The procedure adopted under ethanol soluble extractive was followed using 
chloroform as a solvent. 
Determination of acetone soluble extractive: 
The procedure adopted under ethanol soluble extractive was followed using acetone 
as a solvent. 
Determination of ethyl acetate soluble extractive:     
The procedure adopted under ethanol soluble extractive was followed using ethyl acetate as a 
solvent. 
The extractive values obtained for different solvents were presented in Table 4.  
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                                                                 TABLE-4 
                                                   EXTRACTIVE VALUES 
                                                   BY COLD MACERATION 
 
 
 
 
 
 
Determination of Foaming Index [66] 
 Some plant materials when shaken with water cause persistent foam which may be 
attributed to the presence of saponins in that material. The foaming ability of an aqueous 
solution of plant materials and their extracts is measured in terms of foaming index.  
Procedure 
 An accurate quantity of about 1g of the coarse plant material was weighed and 
transferred into an Erlenmeyer flask containing 100ml of boiling water. The flask was boiled 
at moderate heat for 30min. The solution was cooled and filtered into a 100ml volumetric 
flask and sufficient distilled water was added to dilute to volume. The solution was poured 
into ten stoppered test tubes in successive portions of 1ml, 2ml etc. upto 10ml and the volume 
of the liquid in each tube was adjusted with water upto 10ml. The tubes were then stoppered 
and shaken in a length wise motion for 15sec (two shakes/sec) and allowed to stand for 
15min. The height of foam was measured.  If the height of the foam in every tube was less 
than 1cm, the foaming index was less than 100. If the height of foam was measured 1cm in 
S.NO SOLVENTS USED EXTRACTIVE VALUE 
(%W/W) 
1 Petroleum ether 30.07 
2 Ethyl acetate 6.55 
3 Chloroform 4.87 
4 Ethanol 11.31 
5 Acetone 9.28 
6 Water 26.38 
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any test tube, the volume of the plant material decoction in that tube (A) was used to 
determine the index.  If the height of the foam was more than 1cm in every tube, the foaming 
index was over 1000. In this case, the determination was repeated using a new series of 
dilution of the decoction in order to obtain a result. The foaming index was calculated by 
using the following formula 1000/A where A was the volume in ml of the decoction used for 
preparing the dilution in the tube where foaming to a height of 1cm was observed.  
          The height of the foam in every tube was less than 1cm hence the foaming index was 
found to be less than 100. 
 
SECTION-E 
POWDER ANALYSIS 
 The powdered crude drug analysis was aimed to study and also to assess the quality of 
herbal drugs for therapeutic value which are generally studied by classical Pharmacognostical 
studies. The authenticity of herbal drugs was confirmed by comparison of their powder 
characteristics. 
Procedure 
a. Fluorescence analysis  
The fluorescence analysis of the various extracts of Gmelina arborea was carried out by 
using the method of Chase and Pratt (1949) [69]. The observations were tabulated in Table 5. 
 
 
 
                                                                                              Pharmacognostical Studies 
 
Department of Pharmacognosy, MMC Page 33 
 
Table 5: Fluorescence analysis of various extract of Gmelina arborea leaves 
Extract Day light UV light(254nm) 
UV light 
(366nm) 
Pet. Ether Light brown Light green Green 
Ethyl acetate Green Dark green Orange 
Aqueous Light brown light green Green 
Chloroform Brown Brownish green Orange 
Acetone Green Dark green Orange 
Ethanol Green Dark green Orange 
 
b. Powder microscopy 
 The dried plant material was powdered and the powder was passed through sieve no.6 
for the study of powder microscopy. Chloral hydrate, water, iodine, phloroglucinol and 
hydrochloric acid (1:1), lacto phenol etc.were employed as mounting medium. The pictorial 
representations were presented in Fig.11. 
The powder microscopy of leaves shows the following characters 
 Multicellular-uniseriate unbranched epidermal trichomes 
 Fragments of  spongy parenchyma 
 Fragments of palisade cells 
 Epidermal cells with actinocytic stomata 
 Spiral xylem vessel 
 
 
 Fig. 11 : POWDER MICROSCOPY OF Gmelina arborea Roxb. 
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CHAPTER-VI 
PHYTOCHEMICAL EVALUATION 
 
         Phytochemical (from the Greek word phyto, meaning plant) are biologically active, 
naturally occurring chemical compounds found in plants, which provide health benefits for 
humans further than those attributed to macronutrients and micronutrients. [70] They protect 
plants from disease and damage and contribute to the plant’s colour, aroma and flavor. In 
general, the plant chemicals that protect plant cells from environmental hazards such as 
pollution, stress, drought, UV exposure and pathogenic attack are called as phytochemicals 
[71, 72]. Recently, it is clearly known that they have roles in the protection of human health, 
when their dietary intake is significant. 
SECTION-A 
ORGANOLEPTIC EVALUATION 
Nature – Coarse powder 
Colour – Light Green 
Odour – Characteristic odour 
Taste – Slightly bitter taste 
 
SECTION-B 
PRELIMINARY PHYTOCHEMICAL SCREENING 
The shade dried and coarsely powdered leaves of Gmelina arborea and its various 
extracts were subjected to the following chemical tests. [73-75] 
1. Test for sterols 
The powdered leaf was first extracted with petroleum ether and evaporated to a 
residue. Then the residue was dissolved in chloroform and tested for sterols. 
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a.Salkowski’s Test 
A few drops of concentrated sulphuric acid were added to the chloroform solution, 
shaken well and set aside. The lower chloroform layer of the solution turning red in color 
indicates the presence of sterols. 
b.Liebermann – Burchard’s Test 
To the chloroform solution, a few drops of acetic anhydride and 1ml of concentrated 
sulphuric acid were added through the sides of the test tube and set aside for a while. At the 
junction of two layers a brown ring appears and the upper layer turned green colour 
indicating the presence of sterols. 
 
2. Test for carbohydrates 
a. Molisch’s Test 
The aqueous extract of the powdered leaf was treated with few drops of alcoholic-α-
naphthol solution and sulphuric acid. A purple colour indicates the presence of carbohydrates. 
b. Benedict Test: 
The aqueous extract of the powdered leaf was treated with Benedict’s reagent and 
heated on a boiling water bath for half an hour. Red precipitate indicates the presence of free 
reducing sugars. 
c. Fehling’s Test 
The aqueous extract of the powdered leaf was treated with Fehling’s solution I and II 
and heated on a boiling water bath for half an hour. A red precipitate indicates the presence of 
free reducing sugars 
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3. Test for Proteins 
a. Millon’s Test  
A small quantity of aciduous–alcoholic extract of the powdered drug was heated with 
Millon’s reagent. White precipitate turning red on heating indicates the presence of proteins.  
b. Biuret Test  
To one portion of aciduous–alcoholic extract of the powdered drug, 1ml of 10% 
sodium hydroxide solution was added, followed by one drop of dilute copper sulphate 
solution. Violet color indicates the presence of proteins. 
 
4. Test for fixed oil 
Small quantity of leaf powder was pressed between two filter papers. No oil stain 
indicates the absence of fixed oils. 
 
5. Test for Alkaloids 
 About 2g of the powdered material was mixed with 1g of calcium hydroxide and 5ml 
of water into a smooth paste and set aside for 5min. It was then evaporated to dryness in a 
porcelain dish on a water bath. To this 200ml of chloroform was added, mixed well and 
refluxed for half an hour on a water bath. Then it was filtered and the chloroform was 
evaporated. To the residue, 5ml of dilute hydrochloric acid was added. The solution was 
divided into four parts and to the 2ml of each part, the following reagents were added and the 
colour noted below indicates the presence of alkaloids. 
a) Mayer’s Reagent                 -    Cream precipitate produced 
b) Dragendorff’s Reagent       -     Reddish brown precipitate produced 
c) Hager’s Reagent                  -     Yellow precipitate 
d) Wagner’s Reagent              -       Reddish brown precipitate 
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Test for purine group (Murexide test) 
The residue obtained after the evaporation of chloroform as described above was 
treated with 1ml of hydrochloric acid in a porcelain dish and 0.1gm of potassium chlorate 
was added and evaporated to dryness on water bath. Then the residue was exposed to the 
vapour of dilute ammonia solution. No purple colour indicates the absence of purine group of 
alkaloids. 
 
6. Test for Glycosides 
a. Borntrager’s Test 
The powdered leaf was boiled with dilute sulphuric acid, filtered and to the filtrate, 
benzene was added and shaken well. The organic layer was separated to which ammonia 
solution was added slowly. No pink color in the ammonical layer shows the absence of 
anthraquinone glycosides. 
b.Modified Borntrager’s Test 
About0.1g of the powdered drug was boiled for 2min with dilute hydrochloric acid 
and few drops of ferric chloride solution was added, filtered while hot and cooled. The filtrate 
was then extracted with benzene and the benzene layer was separated. Equal volume of dilute 
ammonia solution was added to the benzene extract. No pink color in ammonical layer shows 
the absence of anthraquinone glycosides. 
Test for Cardiac Glycosides (for deoxysugar) 
a. Keller Kiliani Test 
About 1g of the powdered leaf was boiled with 10ml of 70% alcohol for 2min, cooled and 
filtered. To the filtrate 10ml of water and 5 drops of solution of leadsubacetate were added 
and filtered, evaporated to dryness. The residue was dissolved in 3ml of glacial acetic acid. 
To this, 2 drops of ferric chloride solution was added. Then 3ml of concentrated sulphuric 
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acid was added along the sides of the test tube carefully and observed. No reddish brown 
layer indicates the absence of deoxysugar of cardiac glycoside. 
b. Legal test 
 The powdered leaf was dissolved in pyridine, sodium nitroprusside solution was added to it 
and made alkaline. No pink or red colour indicates the absence of cardiac glycosides. 
c. Baljet test 
 To the powdered leaf sodium picrate solution was added. No yellow or orange colour 
indicates the absence of cardiac glycosides. 
Test for coumarin glycosides [76] 
  A small amount of powdered drug was placed in test tube and covered with filter 
paper moistured with sodium hydroxide solution. The covered test tube was placed on water 
bath for several minutes. Then the paper was removed and exposed to UV light. No green 
colour fluorescence was observed indicating the absence of coumarin glycoside. 
 
7. Test for Saponins 
About 0.5g of the powdered drug was boiled gently for 2min with 20ml of water and 
filtered while hot and allowed to cool. 5ml of the filtrate was then diluted with water and 
shaken vigorously. Frothing indicates the presence of saponins. 
 
8. Test for Tannins and phenolic compounds 
 a) A small quantity of the powdered drug was extracted with water. To the aqueous 
extract few drops of ferric chloride solution was added. A bluish black colour was produced 
indicating the presence of tannins. 
  b) To a small quantity of aqueous solution of the powder, a few drops of bromine 
water were added. Decolourisation of bromine water indicates presence of tannins. 
                                                                                            Phytochemical Evaluation 
 
Department of Pharmacognosy, MMC  Page 39 
 
9.  Test for Flavonoids 
a.Shinoda test: 
A little of the powdered drug was heated with alcohol and filtered. To the test solution 
magnesium turnings and few drops of concentrated hydrochloric acid were added and boiled 
for five minutes. Red colour indicates the presence of flavonoids. 
b. Alkali Test 
To the small quantity of test solution, 10% aqueous sodium hydroxide solution was 
added.  Yellow orange color indicates the presence of flavonoids.  
c. Acid Test 
To the small quantity of test solution, few drops of concentrated sulphuric acid was 
added. Yellow orange color indicates the presence of flavonoids. 
 
10. Test for terpenoids 
The powdered leaf was shaken with petroleum ether and filtered. The filtrate was 
evaporated and the residue obtained was dissolved in small amount of chloroform and to the 
chloroform solution tin and thionyl chloride were added. No pink color indicates the absence 
of terpenoids. 
 
11. Test for volatile oil 
About 100gm of fresh leaves were taken in a volatile oil estimation apparatus and 
subjected to hydro distillation for 4 hrs. No volatile oil was observed indicating the absence 
of volatile oil. 
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12. Test for Mucilage 
A few ml of aqueous extract was prepared from the powdered drug and treated with 
ruthenium red. A pinkish red colour indicates the presence of mucilage. The preliminary 
phytochemical evaluation of the leaf powder and the various extracts of the leaves of 
Gmelina arborea were carried out and the results obtained were presented in Table 6 and 
Table7. 
Table 6: Preliminary phytochemical screening for the 
leaf powder of Gmelina arborea 
 
S.NO                                TEST RESULTS 
1. TEST FOR STEROLS  
 a. Salkowski’s test + 
 b. Libermann- burchard’s test + 
2. TEST FOR CARBOHYDRATES  
 a.Molisch’s test + 
 b. Benedict’s test + 
 c. Fehling’s test + 
3. TEST FOR PROTEINS  
 a.Millon’stet + 
 b. Biuret test + 
4. TEST FORFIXEDOILS - 
5. TEST FOR ALKALOIDS  
 a. Mayer’s reagent + 
 b. Dragendorff’s reagent + 
 c. Hager’s reagent + 
 d. Wagner’s reagent + 
6. TEST FOR GLYCOSIDES  
 a. Anthraquinone glycosides  
     i) Borntrager’s test - 
     ii) Modified Borntrager’s test - 
 b. Cardiac glycosides  
     i) Keller Kiliani test  - 
     ii) Baljet test - 
7. TEST FOR SAPONINS + 
8. TEST FOR TANNINS  
 a) FeCl3 test  + 
 b) Lead acetate test + 
9. TEST FOR FLAVONOIDS  
 a. Shinoda test + 
 b. Alkali test + 
10. TEST FOR TERPENOIDS - 
11. TEST FOR VOLATILE OILS - 
12. TEST FOR MUCILAGE + 
(+) indicates positive reaction         (-) indicates negative reaction 
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Table 7: Preliminary Phytochemical Screening for the various extracts 
of leaf powder of Gmelina arborea Roxb. 
 
Tests Petroleum 
ether 
extract 
Ethyl 
acetate 
extract 
Chloro 
form  
extract 
Methanol 
Extract 
Ethanol 
Extract 
Aqueous 
Extract 
1.Test for sterols       
a.Salkowski’s test + + + - - - 
b.Liebermann-Burchard’s test + + + - - - 
2.Test for carbohydrates       
a. Molisch’s test - - - + + + 
b. Fehling’s test - - - + + + 
c. Benedict’s test - - - + + + 
3.Test for Proteins       
a. Millon’s test - - - - - + 
b. Biuret test - - - - - + 
4.Test for Fixed oils - - - - - - 
5.Test for Alkaloids       
a. Mayer’s reagent - - - + + - 
b. Dragendorff’s reagent - - - + + - 
c. Hager’s reagent - - - + + - 
d. Wagner’s reagent - - - + + - 
6.Test for Glycosides       
a.  Anthraquinone 
glycosides       
i) Borntrager’s test - - - - - - 
ii) Modified Borntrager’s 
test - - - - - - 
b. Cardiac glycosides       
i) Keller Kiliani test - - - - - - 
ii) Baljet test - - - - -  
iii) Coumarin glycosides - - - - - - 
7. Test for Saponins 
 - - - + + + 
8.Test for Tannins       
a. FeCl3 test - + - + + + 
b. Lead acetate test - + - + + + 
9.Test for Flavonoids       
a. Shinoda test - - - + + - 
b. Alkali test - - - + + - 
c.Acid test       
10. Test for Terpenoids - - - - - - 
11. Test for Volatile Oils - - - - - - 
12. Test for Mucilage - - - - - + 
(+) indicates positive reaction                 (-) indicates negative reaction 
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From the table, it can be observed that the ethanol extract showed the presence of 
carbohydrates, saponins, alkaloids, flavonoids, Tannin and phenolic compounds while the 
petroleum ether and chloroform extracts showed the presence of sterols. The ethyl acetate 
extract showed the presence of sterols and tannins. The aqueous extract showed the presence 
of carbohydrate, protein, saponin, tannin and mucilage. 
 
 
 
SECTION-C 
QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS [77-79] 
The quantitative estimation of phytoconstituents is very essential for identifying and 
quantifying the phytochemicals present in the medicinal plants which is important for 
therapeutic action. A particular group of compound   present in the crude extracts can be 
quantified by means of using standard or reference marker compound and then reporting 
them as equivalent to that much amount of compound present in that extract as per standard 
compound. All the phenolic compounds are oxidised by the Folin-Ciocalteu Reagent. 
 
1. Determination of total phenolic content  
Principle 
 The total phenol content of Gmelina arborea was determined by the Folin-Ciocalteu 
colorimetric method (Singleton et al., 1999). The Folin Ciocalteu reagent is a mixture of 
phosphomolybdate and phosphotungstate. The method measures the amount of substance 
needed to inhibit the oxidation of the reagent.   
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Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
 10% sodium carbonate 
 1N Folin-Ciocalteu reagent (diluted with equal volume of water and made 1N) 
Procedure 
0.5ml and 1ml of ethanolic extracts of Gmelina arborea (1mg/ml) were taken in 
separate test tubes. 0.5ml of FolinCiocalteu reagent (1N) was added and allowed to stand for 
15 mins. Then 1ml of 10% sodium carbonate solution was added. Finally the mixtures were 
mixed with distilled water and made upto10ml, allowed to stand for 30 minutes at room 
temperature and total phenols were determined by spectrophotometrically at 760nm. The 
reaction mixture without sample was used as blank. Gallic acid at different concentration i, 
e.20, 40, 60, 80, 100µg/ml was taken and treated in the same manner and the absorbance was 
measured at 760nm.  
A calibration curve was generated by plotting concentration versus absorbance 
(Fig.12). A regression equation was constructed and using the equation, the total phenol 
content of ethanolic extracts of Gmelina arborea was expressed in terms of mg of Gallic acid 
equivalent per gm of extract (mg GAE/g) in Table8. 
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Table8: Total phenolic content in ethanolic extract of Gmelina arborea 
in terms of gallic acid equivalents 
 
S. 
No. 
Conc. of 
gallic acid 
in µg/ml 
Absorbance at 
760nm 
Conc. of 
ethanolic 
extract in 
µg/ml 
Absorbance 
at 760nm* 
Amount of total 
phenolic content in 
terms mgGAE/g of 
extract* 
1 20 0.229 ± 0.010 50 0.258±0.02 49.46±4.01 
2 40 0.452 ± 0.006 100 0.508±0.03 99.4±5.64 
3 60 0.695 ± 0.005  
Average 74.43±4.825 4 80 0.918 ± 0.031  
5 100 1.162 ± 0.028  
* mean of three readings ±SEM 
 
Fig.12: Calibration curve of gallic acid 
 
The linear regression equation was found to be y = 0.116x-0.004 while the correlation 
was found to be 0.9998. The amount of phenolic content present in the extract in terms mg 
GAE/g of extract was found to be 74.43±4.825by using the above linear regression equation. 
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2. Determination of total flavonoid content [80-82] 
Principle 
The aluminum chloride colorimetric technique was used for estimation of total 
flavonoid estimation. Aluminum ions form stable complexes with C4 keto group and either to 
C3 or C5 hydroxyl groups of flavones and flavonols in acidic medium. It also forms acid 
labile complexes with ortho hydroxyl groups in the A or B rings of flavonoids. These 
complexes showed a strong absorption at 415nm which is used for the estimation of 
flavonoids.  
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents  
10% aluminum chloride 
1M potassium acetate 
Procedure  
An aliquot quantity of quercetin was dissolved in ethanol to get a stock solution of 
1mg/ml. Further dilutions were made to get concentrations ranging from 20-100µg/ml. 1ml 
of the above standard solutions were taken in different volumetric flasks, 0.1ml of aluminum 
chloride solution, 0.1ml of potassium acetate solution and 2.8ml of ethanol were added and 
the final volume was then made up to 5ml with distilled water. After 20min the absorbance 
was measured at 415nm. A sample without aluminium chloride was used as a blank. From 
the absorbance obtained, a calibration curve was constructed by plotting concentration versus 
absorbance of quercetin (Fig.13).0.5ml and 1ml of ethanolic extract of Gmelina arborea  
leaves of(1mg/ml) were taken and the reaction was carried out as above and the absorbance 
was measured at 415nm after 20min and the readings were tabulated in Table9. The amount 
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Calibration curve of quercetin
y = 0.0307x - 0.0432
R2 = 0.9974
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of flavonoids present can be determined by linear regression analysis. The total flavonoid 
content was expressed as mg quercetin equivalents /g of extract. 
 
Table9: Total flavonoid content per gram of extract in terms of quercetin 
by aluminium chloride method 
 
S. No. 
Conc. of 
quercetin 
in µg/ml 
Absorbanc
e at 700nm 
Conc. of 
methanolic 
extract in 
µg/ml 
Absorbance 
at 700nm 
Amt of total 
flavonoid content in 
terms mg quercetin 
equivalent/ g of 
extract 
1 20 0.589±0.01 100 0.107 ± 0.01 48.93±2.13 
2 40 1.151±0.04 200 0.286 ± 0.05 53.72±7.52 
3 60 1.710±0.09  
Average 51.32±4.82 4 80 2.390±0.03  
5 100 3.112±0.03  
*mean of three readings ± SEM 
 
Fig.13:  Calibration curve of quercetin 
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The linear regression equation was found to be y = 0.0307x-0.0432 while the 
correlation was found to be 0.9974. The amount of flavonoid content present in the ethanolic 
extract of Gmelina arborea in terms mg quercetin equivalent/g of extract was found to be 
51.32±4.82mg/g of extract by using the above linear regression equation.  
 
3. Determination of total tannin content 
Principle 
 Total tannin content of ethanolic extracts Gmelina arborea was determined by Folin 
Denis reagent method (Schanderl, 1970). [83]                
Tannin like compounds reduces phosphotungstomolybdic acid in alkaline solution to produce 
a highly blue coloured solution [84]. The intensity is measured in a spectrometerically at 
700nm 
Reagents 
a) Folin Denis Reagent ( sodium tungstate 100g and phosphomolybdic acid 20gm 
were dissolved in distilled water 750ml along with phosphoric acid 50ml. The 
mixture was refluxed for 2 hr and volume was made up to 1 litre with distilled 
water )  
b) Sodium carbonates solution (10%) 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Procedure 
       0.2ml and 0.4ml of (1mg/ml) ethanolic extracts of Gmelina arborea was taken in 
separate test tubes and mixed with distilled water to made up to the volume of 1ml. Then add 
0.5ml of Folin Denis reagent and allowed to stand for 15 mins, then 1ml of 10% sodium 
carbonate solution was added and  the mixture was mixed with distilled water and made up to 
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10ml, allowed to stand for 30mins at room temperature and the tannin content was 
determined spectrophotometrically at 700nm.  
       The calibration curve was generated by preparing tannic acid at different concentration 
(20, 40, 60, 80,100µg/ml). The reaction mixture without sample was used as blank. The total 
tannin content in the ethanolic extract of Gmelina arborea was expressed as milligrams of 
tannic acid equivalent per gm of extract in Table.10 and Fig.14. 
Table 10: Total tannin content in ethanolic extract of Gmelina arborea in terms of 
tannic acid equivalents 
S. 
No. 
Conc. of 
tannic 
acid in 
µg/ml 
Absorbance 
at 415nm 
Conc. of 
ethanolicextract 
in µg/ml 
Absorbance 
at 415nm 
Amt of total tannic acid 
content in terms mg 
quercetin equivalent/ g of 
extract 
1 20 0.589±0.01 20 0.115 ± 0.004 22.8±0.92 
2 40 1.151±0.04 40 0.219 ± 0.018 43.66±3.58 
3 60 1.710±0.09  
Average 33.23±2.25 4 80 2.390±0.03  
5 100 3.112±0.03  
*mean of three readings ± SEM 
 
Fig 14: calibration curve for tannic acid 
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The linear regression equation was found to be y = 0.022x-0.003 while the correlation 
was found to be 0.9997. The amount of tannin content present in the ethanolic extract of 
Gmelina arborea in terms mg tannic acid equivalent/g of extract was found to be 
33.23±2.25mg/g of extract by using the above linear regression equation. 
SECTION-D 
CHROMATOGRAPHY [85] 
Chromatography may be defined as the method of separating a multi component 
mixture into individual components through equilibrium distribution between two phases. 
The technique of chromatography was first invented by M.Tswett, a botanist in 1906 in 
Warsaw. Tswett termed chroma and graphos means “colour” and “writing” respectively. The 
technique is mainly based on the differences in the rate at which components of mixture 
move through a porous medium (called stationary phase) under the influence of some solvent 
or gas (called mobile phase). 
The steps involved in the chromatography 
 Adsorption or retention of substances or substances on the stationary phase 
 Separation of adsorbed substances by mobile phase 
 Recovery of separated substances by continuous flow of mobile phase the method 
being called elution 
 Quantitative and qualitative analysis 
Types of chromatography 
The chromatographic methods can be classified based on the nature of the stationary 
and mobile phases used. If the stationary phase is a solid, the principle of separation is called 
as adsorption chromatography and if the stationary phase is a liquid, it is termed as partition 
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chromatography. The various types of chromatography include paper chromatography (PC), 
thin layer chromatography (TLC), column chromatography (CC), gas chromatography (GC), 
high performance liquid chromatography (HPLC) and high performance thin layer 
chromatography (HPTLC) are widely used for plant analysis. 
Thin Layer Chromatography [86] 
Thin layer chromatographic technique is most widely used for the separation and 
identification of active components from plant sources. The principle of separation involved 
here is adsorption. The adsorbent should show a maximum selectivity toward the substances 
being separated so that the differences in rate of elution will be large.  For the separation of 
any given mixture, some adsorbents may be too strongly adsorbing or too weakly adsorbing. 
Depending on the distribution coefficients, the compounds are distributed on the surface of 
the adsorbent. The compound, which is readily soluble but not strongly adsorbed, moves up 
along with the solvent and that not so soluble but more strongly adsorbed move up less 
readily leading to the separation of compounds. 
Preparation of TLC Plates 
 The adsorbent (silica gel G) slurry was prepared in water in the ratio of  
(1: 2). The glass plates (20cm x 5cm) were cleaned and laid in a row as a template, the 
suspension was poured into Stahl TLC spreader, which was adjusted to 0.25mm thickness 
and coated in a single passage of the spreader over them. These plates were air dried and 
activated in hot air oven at 105ºC for 30min and kept in a dessicator. The plates were used as 
the stationary phase or Pre-coated aluminum plates coated with silica gel G F254 (Merck) 
were also used for analysis.  
Sample application  
The sample was prepared by dissolving the ethanolic extract of Gmelina arborea in 
ethanol to get 5mg/ml. The sample was applied as a spot with the help of capillary tube.  
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Development of the chromatogram 
The TLC plates were developed in a chromatographic tank by using different mobile phase’s 
viz., solvent system I, solvent system II. The plates were allowed to develop ¾ of the length 
and then removed. The solvent front was immediately marked and the plates were allowed to 
dry and then it was examined by visually, under UV light at 254 and 365nm.The results were 
presented in Table11. 
Stationary phase            : Silicagel G 
Mobile phase                  : 1.Ethyl acetate: Benzene (2:8) 
                                            2. Chloroform: Ethyl acetate (60:40) 
Detecting agent             : Visual and UV light 
The Rf value of the spots obtained were calculated using the formula 
                                                Distance travelled by solute 
                       Rfvalue =       -------------------------------------- 
                                                Distance travelled by solvent 
 
 
The photographic representation of the chromatogram presented in Fig.15 and the Rf values 
of the spots at 254and365nm were presented in Table11. 
                                   
                                  Table 11: TLC of the ethanolic extract of Gmelina arborea 
 
S. No Solvent system Detecting agent No of spots Colour of spots Rf values 
1. Ethyl acetate: 
Benzene (2:8) 
 
 
Under UV light at 
365nm 
 I Yellow 0.37 
II Orange fluorescence 0.8 
III Yellow 0.92 
2. Chloroform: 
Ethyl 
acetate(60:40) 
Under UV light at 
365nm 
I Yellow 0.23 
II Orange fluorescence 0.8 
III Yellow 0.92 
 
  
 
TLC OF ETHANOLIC EXTRACT OF Gmelina arborea leaves 
 
  Solvent system-I                 Solvent system-II 
      @365 nm      @365 nm 
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The extract showed fluorescent spots at an Rf value of 0.37, 0.8, 0.92 and 0.23, 0.8, 
0.92 when viewed under UV at 365nm after development in the mobile phases. 
High Performance Thin Layer chromatography [87] 
          High-performance thin-layer chromatography (HPTLC) has been emerged as an 
important tool for the qualitative, semi quantitative, and quantitative phytochemical analysis 
of the herbal drugs and formulations. This includes developing TLC fingerprinting profiles 
and estimation of biomarkers. This review has an attempt to focus on the theoretical 
considerations of HPTLC and some examples of herbal drugs and formulations analyzed by 
HPTLC. Standardized manufacturing procedures and suitable analytical tools are required to 
establish the necessary framework for quality control in herbals. Among those tools, high-
performance liquid chromatography (HPLC), high-performance thin layer chromatography 
(HPTLC), and capillary electrophoresis are the most widely used to establish reference 
fingerprints of herbs, against which raw materials can be evaluated and finished products can 
be assayed. High-performance thin-layer chromatography, also known as planar 
chromatography, is a modern technique with high separation power and reproducibility 
superior to classical TLC. Main difference of HPTLC and TLC is particle and pore size of 
sorbents. 
 Special features of HPTLC 
1. Simultaneous processing of sample and standard – better analytical precision 
and accuracy and less need for internal standard 
2. Several analysts can work simultaneously 
3. Lower analysis time and less cost per analysis 
4. Low maintenance cost 
5. Simple sample preparation – can handle samples of divergent nature 
6. No prior treatment for solvents like filtration and degassing 
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7. Low mobile-phase consumption per sample 
8. No interference from previous analysis – fresh stationary and mobile phases for each 
analysis, no contamination 
9. Visual detection possible – open system 
L0.Non-UV-absorbing compounds detected by post chromatographic derivatization 
HPTLC evaluation of ethanolic extract of Gmelina arborea 
Instrument used : CAMAG make HPTLC. 
Software  : win CATS 1.4.3 
Sample Applicator : Linomat 5. 
Detection  : @520nm, @254nm & @366nm in Densitometry TLC Scanner 3 
Sample preparation      : sample was dissolved in 1 ml methanol  
Stationary Phase : HPTLC plates silica gel 60 F 254. 
Mobile Phase             : Ethyl acetate: Toluene (2:8) 
Sample Solution : 2l sample is applied as 8mm band. 
    The visualization of the TLC plate of ethanolic extract of Gmelina arborea at 254 and 
365nm and white light was presented in Fig.16. The 3D display of the chromatogram and the 
peak area of the corresponding area under the curve were presented in Table12. 
High Performance Thin layer Chromatography 
The visualization of the TLC plate of ethanolic extract of Gmelina arborea at 254nm 
and 366nm is presented in Fig.16. The photo of plate at 254nm shows the presence of 8 spots 
while at 366nm shows the presence 9 spots. The 3D display of the fingerprint profile and the 
peak display of ethanolic extract of Gmelina arborea at 254nm and 366nm is presented in 
Figs.17&18. The display at 254nm shows the presence of 8 peaks while at 366nm shows the 
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 Fig. 18: Peak display of ethanolic extract of Gmelina arborea at 254nm and 366nm. 
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presence 9 peaks. The Rf values of the peaks along with the area under the curve for each 
peak at 254 and 366 nm were tabulated in Table12. 
Table 12: Rf values and area under the curve 
for each peak at 254 and 366nm 
 
S.No 
White light @ 254nm @ 366nm 
Rf value Area  (AU) Rf value Area  (AU) Rf value Area  (AU) 
1 0.44 630.2 0.11 1782.2 0.08 190.8 
2 0.49 1684.8 0.16 223.0 0.16 2626.7 
3   0.21 506.7 0.23 1916.3 
4   0.44 468.4 0.36 2342.5 
5   0.49 1305.4 0.45 3427.8 
6   0.61 2528.4 0.49 11221.6 
7   0.82 1003.0 0.59 1671.9 
8   0.90 3656.7 0.66 1304.7 
9     0.73 1063.1 
 
The HPTLC finger print profile of the ethanolic crude plant extract of Gmelina 
arborea showed various peaks with the Rf values indicates that the plant contains many 
medicinally active compounds were responsible for its therapeutic activity. 
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CHAPTER-VII 
PHARMACOLOGICAL EVALUATION 
 
 
              The ethanolic extract of Gmelina arborea was subjected to pharmacological 
screening and the following activities were carried out namely in-vitro antioxidant activity, 
anti-arthritic activity and in-vivo anti-epileptic activity. 
                                                             
                                                             SECTION-A 
IN-VITRO ANTI OXIDANT ACTIVITY 
 
               Antioxidant compounds in food play an important role as a health-protecting factor. 
Scientific evidence suggests that antioxidants reduce the risk for chronic diseases including 
cancer and heart disease. Primary sources of naturally occurring antioxidants are whole 
grains, fruits and vegetables. Plant sourced food antioxidants like vitamin C, vitamin E, 
carotenes, phenolic acids, Phytate and phytoestrogens have been recognized as having the 
potential to reduce disease risk. Most of the antioxidant compounds in a typical diet are 
derived from plant sources and belong to various classes of compounds with a wide variety of 
physical and chemical properties. Some compounds, such as gallates, have strong antioxidant 
activity, while others, such as the monophenols are weak antioxidants. 
The main characteristic of an antioxidant is its ability to trap free radicals. Highly 
reactive free radicals and oxygen species are present in biological systems from a wide 
variety of sources. These free radicals may oxidize nucleic acids, proteins, lipids or DNA and 
can initiate degenerative disease. Antioxidant compounds like phenolic acids, polyphenols 
and flavonoids scavenge free radicals such as peroxide, hydroperoxide or lipid peroxyl and 
thus inhibit the oxidative mechanisms that lead to degenerative diseases. There are a number 
of clinical studies suggesting that the antioxidants in fruits, vegetables, tea and red wine are 
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the main factors for the observed efficacy of these foods in reducing the incidence of chronic 
diseases including heart disease and some cancers. [88] 
 
Method 1: Free radical Scavenging activity using diphenylpicrylhydrazyl (DPPH) free 
radical 
 
The free radical scavenging activity of the extracts is evaluated by assessing their 
ability to reduce the colour of DPPH in ethanol according to Brand Williams [89]. DPPH 
stable free radical method is an easy, rapid and sensitive way to survey the antioxidant 
activity of specific compound or plant extracts [90].  
Principle 
A simple method that has been developed to determine the antioxidant activity of 
plants utilizes the stable 2, 2-diphenyl-1-picrylhydrazyl (DPPH) radical. The odd electron in 
the DPPH free radical gives a strong absorption maximum at 517nm and is purple in color.  
The color turns from purple to yellow as the molar absorptivity of the DPPH radical at 517 
nm reduces from 9660 to 1640 when the odd electron of DPPH radical becomes paired with 
hydrogen from a free radical scavenging antioxidant to form the reduced DPPH-H.  The 
resulting decolorization is stoichiometric with respect to number of electrons captured [91].  
    DPPH. + AH   DPPH – H + A. 
Instrument 
Shimadzu UV Visible spectrometer, Model 1800 
Reagents 
0.1mM Diphenylpicrylhydrazyl Radical in ethanol. 
Procedure [91, 92] 
A stock solution of 1mg/ml concentration of ethanolic extract of Gmelina arborea 
was prepared. To 1ml of various concentrations (40 to 200µg/ml) of test samples, 4ml of 
DPPH was added. Control was prepared without sample in an identical manner. DPPH was 
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replaced by ethanol in case of blank. The reaction was allowed to complete in the dark for 
about 30min. Then the absorbance was measured at 517nm. Vitamin C was used as standard. 
The percentage scavenging was calculated using the formula 
                            [(Control-Test)/Control] x 100 
A graph was constructed by plotting concentration versus percentage inhibition and a 
linear regression equation calculated. The concentration of the sample required for 50% 
reduction in absorbance (IC50) was calculated using linear regression analysis.  A triplicate 
reading was taken and average was calculated.  The results obtained were presented in 
Table13and Fig.19. 
 
Table 13: Percentage inhibition by ethanolic extract of 
Gmelina arborea and standard ascorbic acid against DPPH at 517nm 
 
S. No. 
Conc. in 
μg/ml 
Percentage 
inhibition by 
ascorbic acid 
Percentage 
inhibition by 
Gmelina arborea 
1 40 76.44±1.73 51.97±4.66 
2 80 81.22±1.13 59.71±4.50 
3 120 90.33±2.38 71.18±1.95 
4 160 93.45±1.47 71.62±1.87 
5 200 95.68±2.02 72.71±2.49 
 IC50 40.68µg/ml 85.39µg/ml 
*mean of three readings ± SEM 
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Fig. 19: Free radical scavenging assay of ascorbic acid and 
ethanolic extract of Gmelina arborea against DPPH at 517nm 
 
 
   
 
2. Total antioxidant activity by Phosphomolybdenum Method 
 
Principle 
 
            Total antioxidant capacity was measured by spectrophotometric method of Prieto et al 
[93]. Phosphomolybdenum method assay is based on the reduction of Mo (VI) to Mo (V) by 
the sample analyte and the subsequent formation of green phosphate Mo (V) complex at 
acidic pH and the absorbance was measured at 695nm. This method is used to determine the 
total antioxidant activity of samples. 
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4mM   ammonium molybdate 
Instruments 
Shimadzu UV Visible spectrophotometer, Model 1800 
 Procedure 
 
An aliquot of 0.3ml of different concentrations (100,150,200,250,300µg/ml) of 
sample solutions was combined with 2.7ml of the reagent solution (H2SO4, sodium phosphate 
and ammonium molybdate). In case of blank, 0.3ml of ethanol was used in place of sample. 
The tubes were incubated for 95°C for 90min. After the mixture was cooled to room 
temperature, the absorbance was measured at 695nm against blank. The standard Ascorbic 
acid was treated in a similar manner. The total antioxidant activity is expressed as the number 
of equivalents of ascorbic acid [94].The results obtained for total antioxidant activity by 
Phosphomolybdenum method was presented in Table 14 and Fig.20. 
 
 
                               Table14: Total antioxidant activity of ascorbic acid  
                                      and ethanolic extract of Gmelina arborea 
S. 
No 
Conc. in 
µg/ml 
Absorbance of 
ascorbic acid 
Conc. in 
µg/ml 
Absorbance of 
ethanolic 
extract 
1 100 0.085 ± 0.005 100 0.066±0.004 
2 150 0.165 ± 0.004 150 0.112±0.013 
3 200 0.206 ± 0.008 200 0.153±0.017 
4 250 0.323 ± 0.004 250 0.172±0.013 
5 300 0.371 ± 0.005 300 0.189±0.004 
*mean of three readings ± SEM 
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Fig. 20: Total antioxidant activity of  
ethanolic extract of Gmelina arborea 
 
 
 
 
Method 3: Reducing power assay [94, 95] 
Principle 
Reducing power assay is a spectrophotometric method and is based on the principle 
that increase in absorbance of the reaction mixture indicates the increase in the reducing 
power of the sample. Antioxidant activity may be due to a variety of mechanism viz., the 
prevention of chain initiation, the binding of transition metal ion catalysts, decomposition of 
peroxides, the reductive capacity and free radical scavenging.  The assay is based on the 
reduction of ferric in potassium ferricyanide to ferrous to form potassium ferrocyanide by the 
sample and the subsequent formation of prussian blue colour with ferric chloride. The 
absorbance of the blue complex is measured at 700nm.  
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     Potassium ferricyanide+ Ferric chloride 
                                                                 Antioxidant 
                    Potassium ferrocyanide + Ferrous chloride 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Materials required 
Ethanolic extract of Gmelina arborea leaves 
Ascorbic acid 
1% w/v Potassium ferricyanide 
10% w/v Trichloro acetic acid   
0.2M, Phosphate buffer (pH 6.6) 
  0.1% w/v Ferric chloride 
Procedure 
The reducing power ability of plant extracts was screened by assessing the ability of 
the test extract to reduce FeCl3 solution as mentioned by Oyaizu et al., (1986).[95]  
             0.2 to 1 ml of ethanolic extract of Gmelina arborea leaves of (1mg/ml) was mixed 
with 0.75ml phosphate buffer and 0.75ml of 1%   potassium ferricyanide [K3Fe(CN6)] and 
incubated at 50oC for 20min.0.75ml of 1% trichloro acetic acid was added to the mixture 
,allowed to stand for 10min. The whole mixture was then centrifuged at 3000rpm for 10min. 
Finally 1.5ml of the supernatant was removed and mixed with 1.5ml of distilled water and 
0.1ml of 0.1%ferric chloride solution and the absorbance measured at 700nm in UV-Visible 
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Spectrophotometer.  Ascorbic acid was used as standard and phosphate buffer used as blank 
solution. The results obtained were presented in Table 15 and Fig.21. 
 
                           Table15: Reducing power of ascorbic acid and  
                                   ethanolic extract of Gmelina arborea 
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Fig. 20: Reducing power of ethanolic extract of Gmelina arborea 
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S. No 
Conc. in 
µg/ml 
Absorbance of 
ascorbic acid 
Conc. 
in 
µg/ml 
Absorbance of 
ethanolic extract 
1 200 0.3686±0.014 200 0.295±0.029 
2 400 0.5650±0.019 400 0.454±0.090 
3 600 0.7763±0.033 600 0.566±0.063 
4 800 1.0600±0.022 800 0.616±0.054 
5 1000 1.0976±0.017 1000 0.753±0.003 
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SECTION-B 
ANTI -EPILEPTIC ACTIVITY 
            Epilepsy is the most common neurological disorders affecting people across all 
nationalities [96]. The word epilepsy is derived from the Greek verb epilamvanein (to be 
seized”, “to be taken hold off”, or “to be attacked”) indicating that the person having a 
seizure is ‘possessed’ or at least out of control [97]. Epilepsy refers to chronic conditions 
characterized by recurrent seizures [96]. Epilepsy is one of the most common neurological 
disorders characterized by sudden, transient alterations of brain function usually with motor, 
sensory autonomic or psychic symptoms often accompanied by loss of, or altered 
consciousness. Several biochemical hypotheses suggest the involvement of decreased activity 
of inhibitory GABA ergic system or increased activity of excitatory amino-acids (glutamate 
and aspartate system) in epilepsy [97]. 
By electrical stimulation of the brain a variety of seizers can be produced. 
The principle being, 
a) Supra maximal electrical shock 
b) Psychomotor electrical shock 
c) Minimal electrical shock 
 
SUPRA MAXIMAL ELECTRO SHOCK (MES) METHOD [98, 99] 
The maximal electro-shock (MES) induced convulsions in animals represent 
grandmal type of epilepsy. This electro-shock assay in rats is used primarily as a indication 
for compounds which are effective in grandmal epilepsy. 
  Male albino wistar rats are stimulated through pinna electrodes (150mA current for 
0.2sec- stimulus duration) 
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The resultant seizure in normal rats shows a tonic phase of limb flexion around 2 
seconds, followed by full tonic extension phase around 10-13 seconds and a few clonic jerks. 
Thereafter the numbers of post tonic asphyxia death (or) recovery are noted. 
A substance is known to possess anticonvulsant property if it reduces or abolishes the 
extensor phase of MES convulsions. 
REQUIREMENTS 
Animal  :  Male albino wistar rats (200-250gm) 
Drugs   :  Standard (Phenytoin sodium)25mg/kg/i.p 
Samples   :  70% Ethanolic extract of Gmelina arborea leaves (EEGA) 
Instrument  :  Electro – convulsiometer (Model Ki-9351) Pinna electrodes, stop watch 
PROCEDURE 
Healthy albino wistar rats weighing from 200 – 220 g were selected. They were kept in 
separate cages, fed with balanced diet, water and libitum. Then the animals were divided into 
5 groups each groups containing six animals. 
TREATMENT PROTOCOL 
Group-1     Treated as normal control, received 10ml/kg of normal saline through orally. 
Group-2   Treated as Standard control, received phenytoin sodium (25 mg/kg) through 
intraperitonealy. 
Group-3 Treated as Treatment Control, received 200mg/Kg of ethanolic extract of Gmelina 
arborea administered through orally 
Group-4 Treated as Treatment Control, received 400mg/Kg of ethanolic extract of                       
Gmelina arborea administered through orally 
All the test compounds were dissolved in 2ml sterile water and administered through 
orally. The evaluation was started 60 mins after administration of test compounds. Pinna 
electrodes with the intensity of 150 mA current were used to deliver the stimuli. Inhibition of 
seizure relative to the control was calculated and the data shown on the Table 16. 
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Table 16:Anti-epileptic activity of EEGA by 
Supra maximal electrical shock method 
Treatment Body Wt. Drug Dose 
Duration of 
extension phase 
in seconds 
% inhibition 
of extension 
phase 
Group I 200– 220 gm Normal saline 10 ml / kg 14.65 ± 2.30 - 
Group II 200– 220 gm 
Phenytoin 
sodium 
25 mg / kg 2.6 ± 0.65 82.25 %*a 
Group III 200– 220 gm 
EEGA 
200mg/kg 
200mg/kg 4.65 ± 0.78 68.25 %*a 
Group IV 200– 220 gm 
EEGA 
400mg/kg 
400mg/kg 4.30 ±.0.85 70.64 %*a 
 
 values are expressed as Mean ± SEM 
 Values are find out by using One way ANOVA followed by Newman Keul’s 
multiple range tests. 
 *aValues were significantly different from normal control ( P<0.01) 
 
SECTION-C 
IN-VITRO ANTI -ARTHRITIC ACTIVITY BYPROTEIN DENATURATION 
METHOD 
Rheumatoid arthritis (RA) is a chronic inflammatory condition of the connective 
tissues throughout the body, but especially around the joints. RA is the most common 
inflammatory arthritis and affects about one percent of the population.[100]It is a common 
disease having peak incidence in 3rd to 4th decades of life with 3-5times higher 
preponderance in female.[101]Its prevalence depends upon age. [102] 
 Rheumatoid arthritis is an autoimmune disorder.  One among the cause for the disease 
is due to the denaturation of the protein. Anti-arthritic activity was studied by inhibition of 
protein denaturation method.  
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Instrument  
UV/ Visible spectrophotometer at 416 nm. 
Materials Required 
70% ethanolic extract of leaves of Gmelina arborea 
Bovine serum albumin (5% w/v aqueous solution) 
Phosphate buffer (pH6.3) 
Diclofenac sodium 
Procedure [103-106] 
Preparation of test solutions 
1. Test solution (0.5ml) 
The test solution consists of 0.45ml bovine serum albumin (5% w/v aqueous solution) 
and 0.05ml of 70%ethanolic extract of Gmelina arborea leaves(200-1000µg/ml 
concentrations) 
2. Test control solution (0.5ml) 
The test control solution consists of 0.45ml bovine serum albumin and 0.05ml 
distilled water.   
3. Product control (0.5ml) 
The product control consists of 0.45ml distilled water and 0.05ml of ethanolicextract 
of Gmelina arborea leaves (200-1000 µg/ml concentrations). 
4. Standard solution (0.5ml)  
Standard solution consists of 0.45ml of bovine serum albumin and 0.05ml of 
diclofenac sodium solution. 
All the above test samples were adjusted to PH6.3 using a small amount of 1N HCl. 
They were incubated at 37ºC for 20 min and heated at 57º C for 3 min and allowed to cool and 
about 2.5ml of phosphate buffer (pH 6.3) was added to all the above solutions. The 
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absorbance was measured by using UV spectrophotometer at 416nm.  The percentage 
inhibition of protein denaturation was calculated using the formula. 
 
                Percentage inhibition = 100 - {(OD of test solution-OD of product control)}×100 
                        OD of test control 
 
                    The percentage inhibition of protein denaturation by Gmelina arborea was 
compared with standard diclofenac sodium. The results obtained were presented in Table 17 
and the graphical representation in Fig.22. 
 
 Table 17: Anti-arthritic activity of EEGA by protein denaturation method 
 
S. No. Conc. in 
μg/ml 
Percentage 
inhibition by 
diclofenac sodium 
Percentage 
inhibition by 
Gmelina arborea 
1 200 81.387±8.395 71.533±2.920 
2 400 82.116±8.395 74.237±4.5950 
3 600 83.212±8.760 77.007±2.555 
4 800 83.942±8.760 80.656±0.365 
5 1000 85.036±9.125 82.8498±1.097 
 IC50 189.03µg/ml 275.71 µg/ml 
                                         *mean of three readings ± SEM 
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Fig.22: Effect of diclofenac sodium and Gmelina arborea on 
inhibition of protein denaturation 
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CHAPTER-VIII 
RESULTS AND DISCUSSION 
This dissertation deals with the “Pharmacognostical, Phytochemical and 
pharmacological studies of ethanolic extract of Gmelina arborea leaves” in an attempt to 
rationalize its use as a drug of therapeutic importance. 
CHAPTER –I 
This chapter gives relevant information about the world situation on the traditional 
medicine and herbal drugs in traditional medicine. Drug discovery from natural products and 
various strategies for the discovery of drugs from natural resources were discussed in this 
chapter. Nature and mechanism of epilepsy, classification and medication of epilepsy, 
mechanism of action of anti-epileptic drugs and causes of rheumatoid arthritis, symptoms, 
diagnosis and management of rheumatoid arthritis have also been discussed. 
CHAPTER-II 
In this chapter, the literature review contain the pharmacognostical, phytochemical, 
pharmacological studies on Gmelina arborea and the ethnomedical information about the 
Gmelina arborea Roxb and other related species. 
CHPATER-III 
In this chapter, aim and scope of the study have been discussed. Pharmacognostical 
and phytochemical studies which were planned to carry out for this plant were discussed. 
Pharmacological studies which were planned to carry out for this plant were also discussed in 
this chapter. 
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CHPATER-IV 
In this chapter scientific classification, common name, synonym, vernacular name and 
its distribution and the habit of the plant were discussed. Ethnomedical uses were reported. 
CHAPTER –V 
In this chapter the Macroscopical, Microscopical and physical parameters were 
discussed. 
SECTION-A 
              Morphological characters of bark,leaves,flower,fruit and root-bark of the plant were 
described in detail to identify the plant with the support of photographs and drawing as an 
establishment of authenticity(Fig 2-6) 
  Salient features of the macroscopy of the leaves were observed, such as the leaves are 
simple, opposite- decussate, broadly ovate, 10-25cm long and 7-20cm wide, apically long 
acuminate apex or caudate, entire on mature plants but strongly toothed or lobed on young 
plants. Flowers appear with or sometimes before the young leaves. 
SECTION-B 
This section deals with the microscopical studies of the leaves to ascertain the arrangement of 
tissues.(Fig.7-10) 
The following features have been observed in the transverse section of the leaves of Gmelina 
arborea. 
 The leaf consists of a thick midrib and thin lamina with densely tomentose abaxial 
surface. 
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 The Lamina consist of thick and wide, vertically oblong epidermal cells with 
prominent cuticle. 
 The stomata are actinocytic type. 
 The epidermis bears dense non glandular trichomes. 
 The mesophyll cells consist of adaxial palisade and abaxial spongy parenchyma cells. 
 The palisade cells are single layered with thin vertical, long cylindrical cells and 
cylindrical, spherical or lobed parenchyma cells in spongy mesophyll tissue. 
 The vascular strand consists of two arc shaped collateral bundles. 
 The venation is densely reticulate. The primary, secondary and tertiary veins are thin, 
but distinct .The vein- islets are wide and well defined with prominent vein –
boundaries. The vein- terminations, when present are long, slender and forked at the 
tip. 
SECTION – C 
It deals with the quantitative microscopy such as stomatal number, stomatal index, 
vein - islet number, vein termination number which were determined and tabulated as 
follows. 
Quantitative analytical microscopical 
Parameters of the leaf of Gmelina arborea 
 
S. No. Parameters* Values obtained* 
1. Stomatal number  in lower epidermis 
41.33±0.66 
2. Stomatal index in lower epidermis 
27.33±0.33 
3. Vein islet number 35.67±0.88 
4. Vein termination number 19±0.58 
* mean of 3 readings ± SEM 
 
                                                                                                       Result and Discussion 
 
Department of Pharmacognosy, MMC Page 72 
 
 
SECTION-D 
Physical parameters:  
The following physical parameters like ash values, loss on drying, extractive values, foaming 
index were determined and tabulated. 
Ash values and loss on drying 
 Total ash Acid insoluble ash 
Water soluble 
ash 
Sulphated 
ash 
Loss on 
drying 
Minimum 5 0.16 3.4 9.03 8.5 
Average 7.8 0.23 3.6 9.16 9.0 
Maximum 9.5 0.33 3.9 9.22 9.6 
 
 
Extractive values by cold maceration 
 
 
 
 
 
 
 
S.NO SOLVENTS USED EXTRACTIVE VALUE 
(%W/W) 
1 Petroleum ether 30.07 
2 Ethyl acetate 6.55 
3 Chloroform 4.87 
4 Ethanol 11.31 
5 Acetone 9.28 
6 Water 26.38 
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SECTION-E 
A.Fluorescence analysis 
Extract Day light UV light (254nm) 
UV light 
(366nm) 
Pet. Ether Light brown Light green Green 
Ethyl acetate Green Dark green Orange 
Aqueous Light brown light green Green 
Chloroform Brown Brownish green Orange 
Acetone Green Dark green Orange 
Ethanol Green Dark green Orange 
 
B.Powder microscopy 
The following anatomical characters were observed with powder microscopy of leaves 
reveals the presence of 
 Multicellular-uniseriate unbranched epidermal trichomes 
 Fragments of  spongy parenchyma 
 Fragments of palisade cells 
 Epidermal cells with actinocytic stomata 
 Spiral xylem vessel 
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CHAPTER –VI 
Phytochemical studies 
SECTION-A 
This deals with the organoleptic evaluation of the leaves of Gmelina arborea Roxb. 
SECTION-B 
Preliminary phytochemical screening: 
This chapter was deals with the phytochemical studies of the leaves of Gmelina 
arborea. The results obtained for the preliminary phytochemical screening of the various 
extracts of plant material were presented in Tables 6 and 7.From the table, it can be observed 
that the ethanolic extract of Gmelina arborea leaves showed the presence of carbohydrates, 
saponins, alkaloids, flavonoids, Tannin and phenolic compounds while the petroleum ether 
and chloroform extracts showed the presence of sterols. The aqueous extract showed the 
presence of carbohydrate, protein, saponins and tannin. 
SECTION-C 
1. Determination of total phenolic content  
The total phenolic content for the ethanolic extract of Gmelina arborea leaves was 
found to be 74.43±4.825mg/gm respectively, and shown in Table 8. Phenolic substances are 
known to possess the ability to reduce oxidative damage and act as antioxidants.  
2. Determination of total flavonoid content 
The total flavonoid content for the ethanolic extract of Gmelina arborea leaves was found to 
be   51.32±4.82mg/gm respectively, and shown in Table 9. 
3. Determination of total tannin content 
The total tannin content for the ethanolic extract of Gmelina arborea leaves was found to be 
33.23±2.25mg/gm respectively, and shown in Table 10. 
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         These substances associated with antioxidant activity and played important role in 
stabilizing lipid per-oxidation. 
 
SECTION-D 
TLC and HPTLC STUDIES 
1. TLC 
Thin layer chromatography studies were carried out for the ethanolic extract of 
Gmelina arborea using Ethyl acetate: Benzene and Chloroform: Ethyl acetate as solvent 
systems and the reports were presented in the Table.11. 
Table 11: TLC of the ethanolic extract of Gmelina arborea 
 
S. No Solvent system Detecting agent No of spots Colour of spots Rfvalues 
1. Ethyl acetate: 
Benzene (2:8) 
Under UVlight at 
365nm 
 I Yellow 0.37 
II Orange 
fluorescence 
0.8 
III Yellow 0.92 
2. Chloroform:Eth
ylactate 
(60:40) 
Under UVlight at 
365nm 
I Yellow 0.23 
II Orange 
fluorescence 
0.8 
III Yellow 0.92 
 
 
2. HPTLC 
The HPTLC chromatogram for the ethanolic extract of Gmelina arborea leaves 
showed 8 peaks at 254nm and the Rf values were found to be 0.11, 0.16, 0.21, 0.44, 0.49, 
0.61, 0.82, 0.90.Nine peaks at 366nm and the Rf values were found to be 0.08, 0.16, 0.23, 
0.36, 0.45, 0.49, 0.59, 0.66, 0.7.The HPTLC finger print profile of the ethanolic extract of 
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Gmelina arborea showed various peaks having different Rfvalues indicates that the plant 
contains many medicinally active compounds which may be responsible for its therapeutic 
activity. 
 
CHAPTER-VII 
SECTION-A 
In-vitro anti - oxidant activity 
Method 1: Free radical Scavenging activity using diphenylpicrylhydrazyl (DPPH) free 
radical 
 
From the results obtained it has been observed that the ethanolic extract of Gmelina 
arborea leaves showed a percentage inhibition of 72.71%while the standard, ascorbic acid 
showed  a percentage inhibition of 95.68%at a concentration of  200µg/ml (showed in Fig.19 
and Table 13). The IC50value was found to be 85.39µg/ml and 40.68μg/ml for the ethanolic 
extract of Gmelina arborea leaves and ascorbic acid respectively. The extract possessed a 
good radical scavenging capacity. 
Method 2: Total antioxidant activity by Phosphomolybdenum Method 
 
It is observed that the ethanolic extract of Gmelina arborea leaves showed an 
absorbance of 0.189±0.004for a concentration of 300µg/ml while ascorbic acid showed an 
absorbance 0.371±0.005 at a concentration of 300µg/ml.(showed in Fig.20 and Table 14. 
 Method 3: Reducing power assay  
It is observed that the ethanolic extract of Gmelina arborea showed an absorbance of 
0.753±0.003 for a concentration of 1mg/ml while ascorbic acid showed an absorbance 
1.0976±0.017 at a concentration of 1mg/ml. (showed in Fig.21 and Table 15). 
The ethanolic extract of Gmelina arborea leaves, which contains large amount of 
phenolic compounds, exhibits high antioxidant and free radical scavenging activities. It also 
chelates iron and has reducing power. These in-vitro assays indicate that this plant extract is a 
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significant source of natural antioxidant, which might be helpful in preventing the progress of 
various oxidative stresses. 
SECTION-B 
 
ANTI-EPILEPTIC ACTIVITY 
 
This study deals with the in-vivo pharmacological screening of anti-epileptic activity 
of Gmelina arborea by supra maximal electro shock method. From the results obtained, it has 
been observed that, the percentage inhibition of seizures for the ethanolic extract of Gmelina 
arborea leaves was found to be68.25% and70.64%at a dose of 200mg/kg and 400mg/kg. The 
standard phenytoin sodium shows 82.25% at a dose of 25mg/Kg (showed in Table.16). This 
study reveals that the ethanolic extract of Gmelina arborea leaves possesses significant anti-
epileptic activity (P<0.01). The extract was reducing the duration of extensor phase 
significantly when compared to normal control. 
 
SECTION-C 
IN-VITRO ANTI-ARTHRITIC ACTIVITY BY PROTEIN DENATURATION 
METHOD 
Denaturation of protein is one of the causes of rheumatoid arthritis. The production of 
auto antigens in certain rheumatic diseases may be due to protein denaturation which 
involves the alteration of electrostatic hydrogen, hydrophobic and disulphidebonding [107].The 
protein used in this study is bovine serum albumin. Denaturation of protein is carried out by 
heating. The aim of this activity is to inhibit protein denaturation and to exhibit protective 
effect against rheumatoid arthritis. 
From the results obtained, it has been observed that, the percentage inhibition of 
albumin denaturation by ethanolic extract of Gmelina arborea leaves was found to be 82.85% 
and for standard diclofenac sodium 85.04% at a concentration of 1mg/ml (showed in the Fig 
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.22and Table 17).The IC50value was found to be 275.71 µg/mland189.03μg/ml for ethanolic 
extract of Gmelina arborea leaves and diclofenac sodium respectively. This study showed 
that the extract has a significant anti-arthritic activity. 
The extract showed good antioxidant properties which may be due to the presence of 
phenolic compounds and flavonoids in the extract. A very good in-vitro protein denaturation 
effect showed that the plant extract has significant anti-arthritic activity. 
 
 
 
 
 
 
 
 
SUMMARY AND 
CONCLUSION 
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CHAPTER-IX 
SUMMARY AND CONCLUSION 
This dissertation entitled “Pharmacognostical, Phytochemical, and Pharmacological 
evaluation on the leaves of Gmelina arborea Roxb. (Verbenaceae).The macroscopical, 
microscopical characters, powder analysis, quantitative microscopy and standardization 
parameters like ash value, extractive value, loss on drying and fluorescence have been studied 
and presented. 
The gist of the findings derived from the investigation under this project is furnished 
in the following concluding lines. 
 Pharmacognostical parameters have been determined for the leaf of Gmelina arborea 
Roxb in order to substantiate and identify the plant for future work.  
 The kinds of microstructures have been recognized as tools to measure the 
phylogenetic relationship under light microscope, to resolve taxonomic controversies and to 
establish the botanical identity of the plant. 
 Preliminary phytochemical screening of the leaf of Gmelina arborea Roxb reveals the 
presence of sterols, carbohydrates, protein, alkaloids, flavonoids, tannin and mucilage. 
Determination of tannins, phenolic content and flavonoid content confirms that 
significant concentrations of these phytoconstituents are present in the ethanolic extract of 
Gmelina arborea Roxb. 
TLC studies were performed with the ethanolic extract of the leaf to identify the 
phytoconstituents present in the leaf of this plant. 
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HPTLC finger print studies were performed to evaluate the active constituent present 
in the leaf of Gmelina arborea Roxb. 
Pharmacological screening confirms that the ethanolic extract of Gmelina arborea 
leaves showed significant antioxidant activity which was evaluated by 
Free radical scavenging by DPPH assay 
Total antioxidant activity 
Reducing power assay 
The ethanolic extract of Gmelina arborea leaves showed significant anti-epileptic 
activity which was evaluated by MES method. 
The result of the anti-epileptic activity study clearly indicate that the ethanolic extract 
of Gmelina arborea leaves has significant anti-epileptic activity as assessed by the reduction 
in time of tonic extensor phase of MES TEST as shown in Table 15. 
The result of the MES TEST (Table 15) reveals that the ethanolic extract possesses 
significant anti-epileptic activity (P<0.01). The extract was reducing the duration of extensor 
phase significantly when compared to normal control. 
So we can conclude that the ethanolic extract of Gmelina arborea leaves had anti-
epileptic activity .However it is difficult at the moment to indicate the exact nature and 
category of such actions of the EEGA which require more investigation before any definite 
conclusion can be drawn in this aspect. 
The ethanolic extract of Gmelina arborea leaves showed significant anti-arthritic 
activity which was evaluated by Protein denaturation method by using bovine serum.  
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The extract showed more anti-arthritic activity compared to standard diclofenac 
sodium. The activities may be due to the presence of tannins, flavonoids and alkaloids. 
The present study provides scientific basis for the folkloric medicinal application of the 
leaves of Gmelina arborea for the treatment of rheumatoid arthritis and epilepsy. 
 The future scope of the work is to isolate the chemical constituents responsible for 
the activities and also to carry out pharmacological screening in vivo models. 
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